UK SMI V 37: Chlamydia trachomatis infection testing by Nucleic Acid Amplification Tests (NAAT)
This consultation has concluded
Download the full outcome
Detail of outcome
Detail of feedback received
Timeline of review process
Date review started: 18 May 2015
Consultation: 16 May 2016 to 31 May 2016
Document discussed at the following working group meetings:
- 20 January 2016
- 1 June 2016
Date document issued: 9 January 2017
This consultation ran from
This consultation asks for comments in relation to V 37: Chlamydia trachomatis infection testing by Nucleic Acid Amplification Tests (NAAT)
Ref: PHE publications gateway number: 2016072 PDF, 1.05MB, 19 pages
Ref: PHE publications gateway number: 2016072 MS Word Document, 1.3MB
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email firstname.lastname@example.org. Please tell us what format you need. It will help us if you say what assistive technology you use.
Public Health England has opened a consultation this week in joint partnership with professional organisations.
This consultation asks for feedback in relation to the Standards for Microbiology Investigations V 37: Chlamydia trachomatis infection testing by Nucleic Acid Amplification Tests (NAAT).
We have refined the process so that UK SMI users can comment more easily if they see no requirement for amendments to the document out for consultation.
This information is as important to the consultation process as comments.